Evidence map›Paper›PMID 27729398›Full record

ArticleRespiratory care2017

Smoking Cessation in Pulmonary Care Subjects: A Mixed Methods Analysis of Treatment-Seeking Participation and Preferences.

Freda Patterson, David S Zaslav, Diana Kolman-Taddeo, Hillary Cuesta, Mary Morrison, Frank T Leone, Aditi Satti

Open access · bronzeAbstract read
In one paragraph

Article in Respiratory care, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. The impact of smoking on lung cancer patients.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

Freda PattersonCenter of Biomedical Research Excellence (COBRE) in Cardiovascular Health and the Department of Behavioral Health and Nutrition, University of Delaware, Newark, Delaware. fredap@udel.edu.
David S ZaslavTreatment Research Institute, Philadelphia, Pennsylvania.
Diana Kolman-TaddeoTemple University Lung Center, Temple University Health System, Ambulatory Care Center, Philadelphia, Pennsylvania.
Hillary CuestaDepartment of Epidemiology and Biostatistics, College of Health Sciences, Temple University, Philadelphia, Pennsylvania.
Mary MorrisonDepartment of Psychiatry and Behavioral Sciences, Temple University School of Medicine Episcopal Campus, Philadelphia, Pennsylvania.
Frank T LeonePulmonary, Allergy, and Critical Care Division, University of Pennsylvania Presbyterian Medical Center, Philadelphia, Pennsylvania.
Aditi SattiTemple University Lung Center, Temple University Health System, Ambulatory Care Center, Philadelphia, Pennsylvania.
Temple Lung Center · USDepartment of Behavioral Health · USPresbyterian Medical Center · KRTemple University · USTemple University Health System · USTreatment Research Institute · US

Funding

Vascular Consequences of Duchenne Muscular DystrophyP20GM113125 · NIGMS · UNIVERSITY OF DELAWARE · PI LENNON, SHANNON L. · 2016 to 2025
$23.3M
NIGMS NIH HHS P20 GM113125
6 · The paper itself

Abstract

backgroundAfrican-American smokers experience disproportionate COPD morbidity. As a front-line COPD behavioral management strategy, smoking cessation is less prevalent among African-American smokers. Identifying barriers and predictors to smoking cessation in this population is important to bridging this disparity.

methodsIn this study, the predictors of enrollment and attendance to a 3-session urban hospital smoking cessation program were examined. A retrospective chart review was conducted for all pulmonary clinic patients who smoked and were referred to the cessation program between June 2013 and May 2014. Demographic, smoking behavior, cardiopulmonary, and health status variables were extracted (N = 253). Second, a qualitative assessment of the beliefs and barriers for smoking cessation and physical activity were examined in a sub-sample of the population (n = 41).

resultsOne-hundred forty-seven of the pulmonary subjects (58%) enrolled in the cessation program, and 40 attended all sessions (16% of the total sample). Participants with COPD (odds ratio = 4.65, P = .030), or had a mother who had cancer (odds ratio = 4.49, P = .027), were more likely to attend the program. Qualitatively, pulmonary care patients who wanted to quit smoking and be more physically active cited: strong beliefs about the inability to engage in these behaviors, belief that quitting and increased activity might exacerbate poor health, and an inability to obtain pharmacotherapy as barriers to adopting these behaviors.

conclusionsSmoking cessation program attendance in this sample of mostly African-American smokers was poor. Increased knowledge about cessation benefits and access to full-course pharmacotherapy, particularly in those without a COPD diagnosis and who do not have a maternal history of cancer, may be high-priority targets to promote cessation program uptake in this population. Increased knowledge and access to safe forms of physical activity may also be beneficial.

Indexed as

Health Knowledge, Attitudes, PracticePatient CompliancePatient PreferenceAgedBlack or African AmericanCoronary Artery DiseaseExerciseFemaleHealth BehaviorHospitals, UrbanHumansMaleMiddle AgedNicotinic AgonistsPulmonary Disease, Chronic ObstructiveRetrospective StudiesNicotinic AgonistsVareniclineCOPDmixed methodsphysical activitypreventionpulmonary caresmoking cessation

Identifiers

PMID27729398
PMCPMC6373846
OpenAlexW2531698969

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.